Wed, Aug 27, 2014, 10:25 AM EDT - U.S. Markets close in 5 hrs 35 mins

Recent

% | $
Quotes you view appear here for quick access.

NanoLogix Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • phloam131314 phloam131314 Jul 14, 2011 10:49 PM Flag

    Interview Transcript

    continued:


    Paul: And what times are we talking about then and you're talking about the BNP technology which is good for detection. What are we talking about?

    Bret: Let's just say average six hours in most cases. Sometimes a little bit less. Sometimes a little bit more. It depends on what the standard growth rate would be for any type of bacteria. When Batelle had done some tests for Anthrax and Bubonic Plague, their Anthrax results with the BNP ... their standard results were normally 24 hours. With the BNP membrane they got results in 6 hours. Now with Bubonic Plague, or Yersinia Pestis the standard results are 48 hours ... and at that, with that 48 hour time we were able to cut the time to 24 hours, so we cut it in half ... which may not sound like much, but if one did have an outbreak of Bubonic Plague, then cutting the time in half can save ten-times as many people.

    Paul: Now you said that you had some interest from Pharmaceutical companies, from Proctor and Gamble Pharma, GSK, interest in the technology. What kind of things are they talking to you about?

    Bret: Yeah, what they've talked to us about is ... you know, we're not privy to all their detection processes for Q&A, or QA/QC, but they have said that any process that would bring in detection times for any bacteria in their manufacturing and lab processes would be a huge economic savings to them for anything under 24 hours, which with most of the bacteria they're dealing with, from what we've seen, we can detect those bacteria in much less than 24 hours.

    P: Can you talk a little bit about how you would differentiate yourselves from other technologies on the market.

    Bret: Oh, certainly. Well the big thing is ... well, let's compare us, for example, to PCR. Our technology only detects live cells. PCR detects DNA trace for any cells that are present ... whether they're live or dead. And, unless something's changed ... dead cells can't hurt you. Dead bacteria aren't a threat. And we've run into that quite a bit with some of the tests we've seen run with our technology. Because some of the confirmation of the presence of bacteria is done with PCR just to double-check ours and see how our times compare to those. And so that's the big thing ... is we detect viable bacteria.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • continued:



      Paul: What other developments do you have?

      Bret: Well the BNF ... there's a second type of technology that gives spot-on antibody and antigen reaction, and then with buffering it is only for live cells. And it can give results, from what we've seen, for the trails that are going on, or the trial that is going on at the University of Texas Health Science Center in Houston for Group-B Streptococcus in anywhere from ... well, they've seen results in as early as 2 hours. Dependable results in 6 hours .... where results are detection of the bacteria, specific identification of the bacteria, and determination of antibiotic sensitivity all within 6 hours. As opposed to 48 to 72 hours with the traditional methods that are dictated by the CDC. So we're very excited about that. Now, what we see for the future is researchers at one bio-defense company, and the aforementioned clinical trail that's going on for Group-B Strep in Houston, should have 3 to 5 papers published this year. And then we're also in a clinical trial for Group-B Strep in Italy with one of the ... probably the leading doctor for infectious diseases for OBGYN. And he believes that he'll be published this year also. So we should have multiple papers published in a number of journals. And I can't .... one's been accepted so far for publication in a very established US journal and I can't reveal that, right now, what the name is. But it should be out within a couple of months. So we see that, and then a lot of interest when we just had ... the NAVY's just submitted a request for an order for BNF kits, and that's a big deal to us, because little outfits like the NAVY don't need FDA approval for use ... just like the EPA ... we work with the EPA on developing a comprehensive water quality test kit for use in all 10 EPA regions, and once that developed they don't need any approval other than their own. So we're pretty excited about all that.

      Paul: Well we certainly hope that you continue to work with the drug industry as well, and we'll check back with you in six months or a year and see how things are going. Bret, thanks so much for talking with us today.

      Bret: You're welcome Paul.

      • 7 Replies to phloam131314
      • Phloam, thanks for doing that. I just love how Bret says "little outfits like the Navy don't need FDA approval for use..." Classic stuff.

        Obviously from all this, one should be able to gather the company is heading in the right direction for sure. It does suck the stock price is what it is from where it once was briefly, but I get the feeling the PPS could explode upward at some point. Things are looking strong IMO and I rather own stock right now in this company then be on the sidelines no matter what the market cap is. In reality it is only .35c a share and you could build a healthy supply of NNLX stock at this point. Just my IMO.

      • I posted this back in March:
        Jason and War- the other day I was sitting next to an young lady who in chit chat I found works for the Navy taking specimens and specifically identifying E.coli from patients. I asked if they used petri dished and she said yes, then I asked how long they wait for results and she said "not that long, just overnight." What if you could get results in 4 hours, I asked. She said "Awesome!! Then I could finish all my samples in one day!"
        With that I whipped out my iPad and showed her the Nanologix site and she was all Wow!! And started writing some notes down right away.
        I still believe it is simply a matter of time until the test kits gain traction in the marketplace.

        As we now see the Navy does see the validity of and is interested in NanoLogix products. Sweet!!!

      • Phloam

        I think the most important statement in that interview, which once stated in these upcoming papers will establish a new "gold standard" in culture testing which will eventually get this bad boy a'moven brother!

        <<< where results are detection of the bacteria, specific identification of the bacteria, and determination of antibiotic sensitivity all within 6 hours.>>>


        Hapy Friday people!
        Andre

      • Petro does this sound like Clinical trial is going on in Europe ?

        <<Paul: What other developments do you have?

        Bret: Well the BNF ... there's a second type of technology that gives spot-on antibody and antigen reaction, and then with buffering it is only for live cells. And it can give results, from what we've seen, for the trails that are going on, or the trial that is going on at the University of Texas Health Science Center in Houston for Group-B Streptococcus in anywhere from ... well, they've seen results in as early as 2 hours. Dependable results in 6 hours .... where results are detection of the bacteria, specific identification of the bacteria, and determination of antibiotic sensitivity all within 6 hours. As opposed to 48 to 72 hours with the traditional methods that are dictated by the CDC. So we're very excited about that. Now, what we see for the future is researchers at one bio-defense company, and the aforementioned clinical trail that's going on for Group-B Strep in Houston, should have 3 to 5 papers published this year. And then we're also in a clinical trial for Group-B Strep in Italy with one of the ... probably the leading doctor for infectious diseases for OBGYN. And he believes that he'll be published this year also. So we should have multiple papers published in a number of journals>

      • Interesting read. Closing in on a year.

      • View More Messages
    • <<Paul: Now you said that you had some interest from Pharmaceutical companies, from Proctor and Gamble Pharma, GSK, interest in the technology. What kind of things are they talking to you about?

      Bret: Yeah, what they've talked to us about is ... you know, we're not privy to all their detection processes for Q&A, or QA/QC, but they have said that any process that would bring in detection times for any bacteria in their manufacturing and lab processes would be a huge economic savings to them for anything under 24 hours, which with most of the bacteria they're dealing with, from what we've seen, we can detect those bacteria in much less than 24 hours.>>

      Since people can't get some positive going I'll help you guys out !
      HUGE ECONOMIC SAVING !!

      • 1 Reply to omarhatesyou
      • BUMP, come on post some positives !

        <<<<Paul: Now you said that you had some interest from Pharmaceutical companies, from Proctor and Gamble Pharma, GSK, interest in the technology. What kind of things are they talking to you about?

        Bret: Yeah, what they've talked to us about is ... you know, we're not privy to all their detection processes for Q&A, or QA/QC, but they have said that any process that would bring in detection times for any bacteria in their manufacturing and lab processes would be a huge economic savings to them for anything under 24 hours, which with most of the bacteria they're dealing with, from what we've seen, we can detect those bacteria in much less than 24 hours.>>

        Since people can't get some positive going I'll help you guys out !
        HUGE ECONOMIC SAVING !!

    • <<Paul: Now you said that you had some interest from Pharmaceutical companies, from Proctor and Gamble Pharma, GSK, interest in the technology. What kind of things are they talking to you about?

      Bret: Yeah, what they've talked to us about is ... you know, we're not privy to all their detection processes for Q&A, or QA/QC, but they have said that any process that would bring in detection times for any bacteria in their manufacturing and lab processes would be a huge economic savings to them for anything under 24 hours, which with most of the bacteria they're dealing with, from what we've seen, we can detect those bacteria in much less than 24 hours.>>

      Did that tell us anything worth while ?

      And what is this

      <<but they have said that any process that would bring in detection times for any bacteria in their manufacturing and lab processes would be a huge economic savings to them for anything under 24 hours.....>>

      so what's holding them back from using our technology ? IF it's a specific validations then say once overcome that we would be a go with those companies. That would be the exciting quote in that part of the Transcript. They really need to be more informative, shareholders are waiting patiently and when they do talk it needs to be better than this.

 
NNLX
0.0972-0.0018(-1.82%)10:10 AMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.